Dutch crowdfunding platform Lendahand acquires French counterpart Babyloan: Know more…
Lendahand aims to eliminate poverty all over the world using crowdfunding.
Contributor
Vishal Singh is a News Reporter and Social Media Marketing Lead at Silicon Canals. He covers developments in the European startup ecosystem and oversees the publication's social media presence. Before joining Silicon Canals, Vishal gained experience at the Indian digital media outlet Inc42, contributing to its growth with insightful content. Despite being a college dropout, his passion for writing has driven his career in journalism.
Lendahand aims to eliminate poverty all over the world using crowdfunding.
Jun 10, 2022
Fung was developed with the goal of merging the crypto and fiat payment rails in order to give customers a seamless experience while also improving the security and dependability of existing solutions.
Jun 10, 2022
LoopingOne is a solution for marketplaces that want the freedom to connect with their preferred payment and KYC solutions via a single platform.
Jun 10, 2022
Recover is a global producer of low-impact, high-quality recycled cotton fibre and cotton fibre blends.
Jun 10, 2022
REDUCED specialises in creating food products made from surplus produce.
Jun 9, 2022
Factris is on a mission to provide quick and affordable capital to SMEs across Europe using financial technology with personalised guidance.
Jun 9, 2022
Instant Commerce is the next-gen frontend-as-a-service platform for e-commerce companies.
Jun 9, 2022
Backbase is a fintech company that is on a mission to re-architect banking around the customer.
Jun 9, 2022
Codat’s API is used by SaaS, lending and payments companies to build integrated products for their SMB customers.
Jun 9, 2022
Bud was born as an education platform designed to improve people’s financial wellbeing. Bud has now become a platform used by global banks to harness the power of open banking.
Jun 8, 2022
Felix Capital claims to be a venture capital firm for the creative class, operating at the intersection of technology and creativity.
Jun 8, 2022
CimCure focuses on the design and development of a novel class of active cancer immunotherapies.
Jun 8, 2022